Structure Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $102,775,000.
Profit Margin
| 2020 | 0 | -15.87K | |
|---|---|---|---|
| 2021 | 0 | -38.04K | |
| 2022 | 0 | -51.32M | |
| 2023 | 0 | -89.62M |
GPCR Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 949.17K | 623.25K | 266.35K | 20.03K |
Gross profit | -949.17K | -623.25K | -266.35K | -20.03K |
Operating exp. | ||||
Research and development | 70.10M | 36.19M | 29.11K | 12.36K |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 102.77M | 52.56M | 37.69K | 15.90K |
Operating income | -102.77M | -52.56M | -37.69K | -15.90K |
Other income (expenses), net | 13.39M | 1.25M | -122 | 168K |
Income before tax | -89.38M | -51.30M | -37.81K | -15.73K |
Income tax expense | 236K | 17K | 231 | 138 |
Net income | -89.62M | -51.32M | -38.04K | -15.87K |
Earnings per share | ||||
Basic EPS | -2.44 | -1.4 | -0.00 | -0.00 |
Diluted EPS | -2.44 | -1.4 | -0.00 | -0.00 |
| Data source | Data source |